These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 2961291)
1. The use of intranasal Atrovent in the treatment of vasomotor rhinitis. Hosen H Ann Allergy; 1987 Nov; 59(5):384. PubMed ID: 2961291 [No Abstract] [Full Text] [Related]
2. Intranasal ipratropium in the treatment of vasomotor rhinitis. Jokinen K; Sipilä P Rhinology; 1983 Dec; 21(4):341-5. PubMed ID: 6229864 [TBL] [Abstract][Full Text] [Related]
3. A trial of intranasal Atrovent versus placebo in the treatment of vasomotor rhinitis. Knight A; Kazim F; Salvatori VA Ann Allergy; 1986 Nov; 57(5):348-54. PubMed ID: 2946252 [TBL] [Abstract][Full Text] [Related]
4. Ipratropium (Atrovent) in the treatment of vasomotor rhinitis of elderly patients. Malmberg H; Grahne B; Holopainen E; Binder E Clin Otolaryngol Allied Sci; 1983 Aug; 8(4):273-6. PubMed ID: 6228347 [TBL] [Abstract][Full Text] [Related]
5. Vasomotor rhinitis and the systemic absorption of ipratropium bromide. Kaila T; Suonpää J; Grénman R; Iisalo E Rhinology; 1990 Jun; 28(2):83-9. PubMed ID: 2143593 [TBL] [Abstract][Full Text] [Related]
10. The relation between permanent administration of Atrovent and the dose of steroids in chronic bronchitis [proceedings]. Ajewski Z; Popiak B Scand J Respir Dis Suppl; 1979; 103():205. PubMed ID: 155299 [No Abstract] [Full Text] [Related]
11. The effect of ipratropium bromide (Atrovent) on the air conditioning capacity of the nose. Kumlien J; Drettner B Clin Otolaryngol Allied Sci; 1985 Jun; 10(3):165-8. PubMed ID: 3161669 [TBL] [Abstract][Full Text] [Related]
12. Long-term safety and efficacy study of intranasal ipratropium bromide. Milford CA; Mugliston TA; Lund VJ; Mackay IS J Laryngol Otol; 1990 Feb; 104(2):123-5. PubMed ID: 2139094 [TBL] [Abstract][Full Text] [Related]
13. Effect of Atrovent administered by inhalation on pulmonary mechanics in patients with obstructive lung disease [proceedings]. Koch G Scand J Respir Dis Suppl; 1979; 103():206-7. PubMed ID: 155300 [No Abstract] [Full Text] [Related]
14. Treatment of perennial secretory rhinitis. Bende M; Rundcrantz H ORL J Otorhinolaryngol Relat Spec; 1985; 47(6):303-6. PubMed ID: 2934671 [TBL] [Abstract][Full Text] [Related]
15. [Use of the cholinolytic preparation Atrovent in high doses at short intervals in patients with chronic bronchial obstruction]. Vŭlcheva T; Popov T Vutr Boles; 1988; 27(5):28-31. PubMed ID: 2975087 [TBL] [Abstract][Full Text] [Related]
16. Ipratropium bromide inhalation for allergic rhinitis and chronic cough. Shore SC; Weinberg EG S Afr Med J; 1981 Feb; 59(8):252. PubMed ID: 6451037 [No Abstract] [Full Text] [Related]
17. [Dexamethasone nose drops in the treatment of vasomotor rhinitis]. Novotný Z; Novotná V Cesk Otolaryngol; 1981 Jan; 30(1):41-8. PubMed ID: 7214570 [No Abstract] [Full Text] [Related]
18. Ipratropium nasal spray: a new treatment for rhinorrhea in the common cold. Borum P; Olsen L; Winther B; Mygind N Am Rev Respir Dis; 1981 Apr; 123(4 Pt 1):418-20. PubMed ID: 6452842 [TBL] [Abstract][Full Text] [Related]